Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Shares Outstanding (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Shares Outstanding data on record, last reported at $83.3 million in Q3 2022.

  • For Q3 2022, Shares Outstanding changed 0.29% year-over-year to $83.3 million; the TTM value through Sep 2022 reached $83.3 million, changed 0.29%, while the annual FY2021 figure was $83.1 million, 0.81% up from the prior year.
  • Shares Outstanding reached $83.3 million in Q3 2022 per AVIR's latest filing, roughly flat from $83.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $83.3 million in Q3 2022 and bottomed at $10.1 million in Q1 2020.
  • Average Shares Outstanding over 3 years is $63.1 million, with a median of $82.8 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: skyrocketed 721.45% in 2021, then increased 0.29% in 2022.
  • A 3-year view of Shares Outstanding shows it stood at $82.4 million in 2020, then rose by 0.81% to $83.1 million in 2021, then grew by 0.22% to $83.3 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $83.3 million in Q3 2022, $83.3 million in Q2 2022, and $83.3 million in Q1 2022.